BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21616094)

  • 1. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
    Ölschläger S; Neyts J; Günther S
    Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
    Leyssen P; Balzarini J; De Clercq E; Neyts J
    J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
    Leyssen P; De Clercq E; Neyts J
    Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
    Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
    Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
    Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
    Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
    Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.
    Smee DF; Bray M; Huggins JW
    Antivir Chem Chemother; 2001 Nov; 12(6):327-35. PubMed ID: 12018677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
    Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
    Balzarini J; Lee CK; Schols D; De Clercq E
    Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents.
    Stuyver LJ; Lostia S; Patterson SE; Clark JL; Watanabe KA; Otto MJ; Pankiewicz KW
    Antivir Chem Chemother; 2002 Nov; 13(6):345-52. PubMed ID: 12718406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.
    Tong X; Smith J; Bukreyeva N; Koma T; Manning JT; Kalkeri R; Kwong AD; Paessler S
    Antiviral Res; 2018 Jan; 149():34-40. PubMed ID: 29126899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Minakawa N; Matsuda A
    Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
    Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
    Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
    Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Junin virus RNA synthesis by an antiviral acridone derivative.
    Sepúlveda CS; García CC; Fascio ML; D'Accorso NB; Docampo Palacios ML; Pellón RF; Damonte EB
    Antiviral Res; 2012 Jan; 93(1):16-22. PubMed ID: 22027649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
    Jashés M; Mlynarz G; De Clercq E; Sandino AM
    Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of antiviral activity of mycophenolic acid on Brazilian orthobunyaviruses.
    Livonesi MC; Moro de Sousa RL; Moraes Figueiredo LT
    Intervirology; 2007; 50(3):204-8. PubMed ID: 17283446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.